ArticleOncoimmunology

Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study.

Shakeel Modak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.